23040689|t|Brivudin induced delirium: a case report.
23040689|a|Brivudin is an oral antiviral agent used to treat herpes zoster infections. Common side effects of brivudin include nausea and headache. This report describes delirium in a patient who used brivudin for herpes zoster treatment, which consequently remitted after drug cessation on the  fourth day of medication use. To our knowledge, no such side effect has been reported to date. However, it is important that clinicians who prescribe brivudin are aware that treatment cessation is likely to result in total clinical recovery.
23040689	0	8	Brivudin	Chemical	MESH:C020235
23040689	17	25	delirium	Disease	MESH:D003693
23040689	42	50	Brivudin	Chemical	MESH:C020235
23040689	92	116	herpes zoster infections	Disease	MESH:D006562
23040689	141	149	brivudin	Chemical	MESH:C020235
23040689	158	164	nausea	Disease	MESH:D009325
23040689	169	177	headache	Disease	MESH:D006261
23040689	201	209	delirium	Disease	MESH:D003693
23040689	215	222	patient	Species	9606
23040689	232	240	brivudin	Chemical	MESH:C020235
23040689	245	258	herpes zoster	Disease	MESH:D006562
23040689	477	485	brivudin	Chemical	MESH:C020235
23040689	Positive_Correlation	MESH:C020235	MESH:D009325
23040689	Positive_Correlation	MESH:C020235	MESH:D003693
23040689	Negative_Correlation	MESH:C020235	MESH:D006562
23040689	Positive_Correlation	MESH:C020235	MESH:D006261

